Woman who had pioneering gene-editing therapy hopes for cure of major blood disorder

Kavita Mehta, pictured, has become one of the first patients in the south of England to receive the gene-editing treatment Casgevy on the NHS - (University College London Hospitals NHS Foundation Trust /PA Wire)

A woman who has undergone a pioneering gene-editing treatment on the NHS is optimistic that 2026 will mark the year she is cured of a severe blood disorder.

Kavita Mehta, 36, from London, suffers from beta thalassaemia, a genetic condition preventing her body from producing sufficient haemoglobin – the vital protein in red blood cells responsible for oxygen transport.